Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine
- 1 January 1985
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 9 (10) , 1255-1261
- https://doi.org/10.1016/0145-2126(85)90153-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cataracts after total body irradiation and marrow transplantation: A sparing effect of dose fractionationInternational Journal of Radiation Oncology*Biology*Physics, 1984
- CYCLOSPORINE-ASSOCIATED CENTRAL NERVOUS SYSTEM TOXICITY AFTER ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1984
- Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromesBritish Journal of Haematology, 1983
- Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapseBlood, 1983
- Cyclosporin A is associated with faster engraftment and less mucositis than methotrexate after allogeneic bone marrow transplantationBritish Journal of Haematology, 1983
- Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients.BMJ, 1982
- FACTORS ASSOCIATED WITH INTERSTITIAL PNEUMONITIS AFTER BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIAThe Lancet, 1982
- Allogeneic marrow transplantation using fractionated total body irradiation in patients with acute lymphoblastic leukemia in relapseLeukemia Research, 1982
- Allogeneic marrow transplantation for acute non-lymphoblastic leukemia in relapse using fractionated total body irradiationLeukemia Research, 1982
- Allogeneic marrow transplantation for acute leukemia in relapseLeukemia Research, 1982